TrialJournal of hematology & oncology2017

Clinical characteristics and outcomes according to age in lenalidomide-treated patients with RBC transfusion-dependent lower-risk MDS and del(5q).

Pierre Fenaux et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.